Prospective Randomized Controlled Clinical Study to Compare Abciximab-Bolus i.v. Versus i.c. in Primary PCI in Patients With Acute ST-Elevation Myocardial Infarction.

Trial Profile

Prospective Randomized Controlled Clinical Study to Compare Abciximab-Bolus i.v. Versus i.c. in Primary PCI in Patients With Acute ST-Elevation Myocardial Infarction.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jul 2017

At a glance

  • Drugs Abciximab (Primary) ; Abciximab (Primary)
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms AIDA STEMI
  • Most Recent Events

    • 07 Nov 2012 ST segment resolution substudy results presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 07 Nov 2012 MRI substudy results presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 07 Nov 2012 Results at 12 months presented at the 85th Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top